18, 2024 — Scientists have generated human stem ... of neural cells. Their findings on a molecular 'bridge' complex demonstrate a new level of ... Chromosomal Chaos Promotes Therapy Resistance ...

With more than $72 million in funding from CIRM, a San Diego-based company named ViaCyte is working on this solution. They have spent years developing new methods to turn human embryonic stem cells ...

Researchers developed spatial aging clocks to map brain cell aging, revealing how T cells accelerate aging and NSCs ...

The first medical treatment to use Crispr gene editing has been on the market for a year. Its complexity means few patients ...

"Blood is drawn out of one arm and fed into an apheresis machine that filters the stem cells out of the blood ... Others must ...

Muscle stem cells are adult stem cells, present in skeletal muscle tissue, which can self-renew and are capable of giving rise to skeletal muscle cells. These stem cells are activated in response ...

It seems imagination is the only limit to AI-based protein design. But there's room for even more progress in 2025.

Cell therapy is a field rife with innovation, but most of the novel therapies being developed fall into one of two basic categories: autologous cell therapies, which involve removing a patient’s ...

The exponential growth in quick commerce has attracted newer ventures, and at the same time, brought in scrutiny and ...

Investigators from Cedars-Sinai and the University of California, San Francisco (UCSF) have identified a new way to deliver instructions that tell stem cells to grow into specific bodily ...

Azacitidine is under clinical development by Bristol-Myers Squibb and currently in Phase II for Pancreatic Ductal Adenocarcinoma.

CTEcells is under clinical development by CTE Biologics and currently in Phase II for Chronic Traumatic Encephalopathy (CTE).